📊 PRVA Key Takeaways
Is Privia Health Group, Inc. (PRVA) a Good Investment?
Privia Health exhibits fundamental operational deterioration masked by revenue growth. Despite 22.3% YoY revenue expansion to $603.8M, the company posted -$49.5M operating cash flow and -$49.6M free cash flow, indicating the core business is not generating cash. Net income declined 22.9% YoY while revenue grew, revealing severe margin compression and unsustainable unit economics.
Privia Health Group, Inc. Key Strengths (PRVA)
- Strong revenue growth of 22.3% YoY demonstrates market demand and business expansion
- Fortress balance sheet with minimal leverage (0.04x debt-to-equity) and $419.5M cash provides financial flexibility to address operational challenges
- Excellent interest coverage of 14.8x and low absolute debt ($33.0M) eliminate near-term solvency risk
PRVA Stock Risks: Privia Health Group, Inc. Investment Risks
- Negative operating cash flow of -$49.5M indicates core business is destroying cash despite revenue generation; at current burn rate provides approximately 8.5 years of runway before cash depletion
- Margin compression is severe: net income declined 22.9% YoY while revenue grew 22.3%, signaling deteriorating profitability and unit economics despite scale
- Profitability metrics are critically low (operating margin 1.2%, net margin 0.5%, ROE 0.4%, ROA 0.2%), suggesting fundamental business model inefficiency in healthcare services delivery
Key Metrics to Watch
- Operating cash flow trend - must return to positive; continued negative OCF is structurally unsustainable
- Operating margin and net margin trajectory - assess whether scale improvements can reverse margin compression
- Cash burn rate by quarter - monitor path to cash flow breakeven and assess runway adequacy
Privia Health Group, Inc. (PRVA) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Privia Health Group, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
PRVA Profit Margin, ROE & Profitability Analysis
PRVA vs Services Sector: How Privia Health Group, Inc. Compares
How Privia Health Group, Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Privia Health Group, Inc. Stock Overvalued? PRVA Valuation Analysis 2026
Based on fundamental analysis, Privia Health Group, Inc. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Privia Health Group, Inc. Balance Sheet: PRVA Debt, Cash & Liquidity
PRVA Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Privia Health Group, Inc.'s revenue has grown significantly by 120% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.19 reflects profitable operations.
PRVA Revenue Growth, EPS Growth & YoY Performance
PRVA Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $480.1M | $3.1M | $0.02 |
| Q3 2025 | $437.9M | $3.5M | $0.03 |
| Q2 2025 | $422.3M | $2.7M | $0.02 |
| Q1 2025 | $415.2M | $3.0M | $0.02 |
| Q3 2024 | $417.3M | $3.5M | $0.03 |
| Q2 2024 | $413.4M | $3.5M | $0.03 |
| Q1 2024 | $386.3M | $3.0M | $0.02 |
| Q3 2023 | $342.9M | $1.6M | $0.01 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Privia Health Group, Inc. Dividends, Buybacks & Capital Allocation
PRVA SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Privia Health Group, Inc. (CIK: 0001759655)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| May 22, 2026 | 4 | xslF345X06/wk-form4_1779452797.xml | View → |
| May 22, 2026 | 4 | xslF345X06/wk-form4_1779452780.xml | View → |
| May 22, 2026 | 4 | xslF345X06/wk-form4_1779452765.xml | View → |
| May 22, 2026 | 4 | xslF345X06/wk-form4_1779452748.xml | View → |
| May 22, 2026 | 4 | xslF345X06/wk-form4_1779452731.xml | View → |
❓ Frequently Asked Questions about PRVA
What is the AI rating for PRVA?
Privia Health Group, Inc. (PRVA) has an AI grade of C with 75% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PRVA's key strengths?
Claude: Strong revenue growth of 22.3% YoY demonstrates market demand and business expansion. Fortress balance sheet with minimal leverage (0.04x debt-to-equity) and $419.5M cash provides financial flexibility to address operational challenges.
What are the risks of investing in PRVA?
Claude: Negative operating cash flow of -$49.5M indicates core business is destroying cash despite revenue generation; at current burn rate provides approximately 8.5 years of runway before cash depletion. Margin compression is severe: net income declined 22.9% YoY while revenue grew 22.3%, signaling deteriorating profitability and unit economics despite scale.
What is PRVA's revenue and growth?
Privia Health Group, Inc. reported revenue of $603.8M.
Does PRVA pay dividends?
Privia Health Group, Inc. does not currently pay dividends.
Where can I find PRVA SEC filings?
Official SEC filings for Privia Health Group, Inc. (CIK: 0001759655) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PRVA's EPS?
Privia Health Group, Inc. has a diluted EPS of $0.02.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is PRVA's fundamental grade?
Based on our AI fundamental analysis in May 2026, Privia Health Group, Inc. has a C grade with 75% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is PRVA stock overvalued or undervalued?
Valuation metrics for PRVA: ROE of 0.4% (sector avg: 16%), net margin of 0.5% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
What is PRVA's AI grade for 2026?
Our dual AI analysis gives Privia Health Group, Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PRVA's free cash flow?
Privia Health Group, Inc.'s operating cash flow is $-49.5M, with capital expenditures of $113.0K. FCF margin is -8.2%.
How does PRVA compare to other Services stocks?
Vs Services sector averages: Net margin 0.5% (avg: 10%), ROE 0.4% (avg: 16%), current ratio 1.61 (avg: 1.5).